Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Cabozantinib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Cabozantinib XL184, BMS-907351 VEGFR2, c-MET Tyrosine kinases Approved Approved Selleck Chemicals S1119

Cell Line (34)
Cell LineAUCGI50
MHCC97H0.560.0772
HCC.30.680.5439
B10.710.6266
JHH40.832.111
JHH50.844.418
SNU3980.847.8
Huh60.862.316
SNU4750.8710.0
Huh70.877.54
SNU3870.910.0
Huh10.9210.0
HepG20.9310.0
HepaRG0.935.237
HCC.1.20.938.101
SNU1820.9410.0


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it